CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients

Published:2024-11 Issue: Volume:231 Page:106005
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Luo Mengqi,Liang Xinghe,Zhou Bin,Hou Jinlin,Jiang De-Ke^ORCID

Publisher

Elsevier BV

Reference44 articles.

1. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes;Balabanian;J. Biol. Chem.,2005

2. Genome-wide association study identifies genetic variants associated with early and sustained response to (pegylated) interferon in chronic hepatitis B patients: the GIANT-B study;Brouwer;Clin. Infect. Dis.,2019

3. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B;Brunetto;Hepatology,2009

4. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development;Burns;J. Exp. Med.,2006

5. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa;Buster;Gastroenterology,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3